JP2013514974A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013514974A5 JP2013514974A5 JP2012544727A JP2012544727A JP2013514974A5 JP 2013514974 A5 JP2013514974 A5 JP 2013514974A5 JP 2012544727 A JP2012544727 A JP 2012544727A JP 2012544727 A JP2012544727 A JP 2012544727A JP 2013514974 A5 JP2013514974 A5 JP 2013514974A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- amino
- compound
- salt
- bicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 13
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- -1 (2S) -2-amino-4-methylsulfanyl-butanoyl Chemical group 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- MWECKFISVWUYDM-UHFFFAOYSA-N bicyclo[3.1.0]hexane-2,6-dicarboxylic acid Chemical compound C1CC(C(O)=O)C2C(C(=O)O)C21 MWECKFISVWUYDM-UHFFFAOYSA-N 0.000 claims 2
- 150000004682 monohydrates Chemical class 0.000 claims 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims 1
- ANUFAWHRSIJTHW-UHFFFAOYSA-N 2-methylheptanedioic acid Chemical compound OC(=O)C(C)CCCCC(O)=O ANUFAWHRSIJTHW-UHFFFAOYSA-N 0.000 claims 1
- OKSYUCYFMKATOR-UHFFFAOYSA-N 2-methylheptanedioic acid;hydrochloride Chemical compound Cl.OC(=O)C(C)CCCCC(O)=O OKSYUCYFMKATOR-UHFFFAOYSA-N 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000029364 generalized anxiety disease Diseases 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382290.6 | 2009-12-21 | ||
| EP09382290 | 2009-12-21 | ||
| US30523910P | 2010-02-17 | 2010-02-17 | |
| US61/305,239 | 2010-02-17 | ||
| PCT/US2010/060371 WO2011084437A1 (en) | 2009-12-21 | 2010-12-15 | Mglu2 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013514974A JP2013514974A (ja) | 2013-05-02 |
| JP2013514974A5 true JP2013514974A5 (OSRAM) | 2014-01-23 |
| JP5779190B2 JP5779190B2 (ja) | 2015-09-16 |
Family
ID=42026702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012544727A Active JP5779190B2 (ja) | 2009-12-21 | 2010-12-15 | Ｍｇｌｕ２アゴニスト |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US8318184B2 (OSRAM) |
| EP (1) | EP2516406B1 (OSRAM) |
| JP (1) | JP5779190B2 (OSRAM) |
| KR (1) | KR101395356B1 (OSRAM) |
| CN (1) | CN102695701B (OSRAM) |
| AR (1) | AR079343A1 (OSRAM) |
| AU (1) | AU2010340039B2 (OSRAM) |
| BR (1) | BR112012017188B1 (OSRAM) |
| CA (1) | CA2784667C (OSRAM) |
| CR (1) | CR20120322A (OSRAM) |
| CY (1) | CY1114880T1 (OSRAM) |
| DK (1) | DK2516406T3 (OSRAM) |
| DO (1) | DOP2012000173A (OSRAM) |
| EA (1) | EA020229B1 (OSRAM) |
| EC (1) | ECSP12011989A (OSRAM) |
| ES (1) | ES2435651T3 (OSRAM) |
| HN (1) | HN2012001160A (OSRAM) |
| HR (1) | HRP20131052T1 (OSRAM) |
| IL (1) | IL220011A (OSRAM) |
| JO (1) | JO2978B1 (OSRAM) |
| MA (1) | MA33824B1 (OSRAM) |
| MX (1) | MX2012007332A (OSRAM) |
| MY (1) | MY160618A (OSRAM) |
| NZ (1) | NZ600305A (OSRAM) |
| PE (1) | PE20121688A1 (OSRAM) |
| PH (1) | PH12012501253A1 (OSRAM) |
| PL (1) | PL2516406T3 (OSRAM) |
| PT (1) | PT2516406E (OSRAM) |
| RS (1) | RS53063B (OSRAM) |
| SG (1) | SG181836A1 (OSRAM) |
| SI (1) | SI2516406T1 (OSRAM) |
| TN (1) | TN2012000281A1 (OSRAM) |
| TW (1) | TWI477490B (OSRAM) |
| UA (1) | UA107684C2 (OSRAM) |
| WO (1) | WO2011084437A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011216404B2 (en) | 2010-02-17 | 2016-04-07 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| AR083845A1 (es) * | 2010-11-18 | 2013-03-27 | Lilly Co Eli | COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3 |
| JP5870111B2 (ja) * | 2010-11-18 | 2016-02-24 | イーライ リリー アンド カンパニー | ｍＧｌｕＲ２／３アンタゴニストとしての４−置換−３−ベンジルオキシ−ビシクロ［３．１．０］ヘキサン化合物 |
| HRP20160676T1 (hr) * | 2011-06-17 | 2016-07-15 | Eli Lilly And Company | Derivati biciklo[3.1.0]heksan-2,6-dikarboksilne kiseline kao agonisti receptora mglu2 |
| AR089718A1 (es) * | 2012-02-01 | 2014-09-10 | Lilly Co Eli | AGONISTAS DE mGlu2/3 |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| ME03518B (me) | 2014-01-21 | 2020-04-20 | Janssen Pharmaceutica Nv | Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena |
| AU2015208233B2 (en) | 2014-01-21 | 2019-08-29 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| MX374909B (es) | 2015-04-01 | 2025-03-06 | Akebia Therapeutics Inc | El uso del inhibidor de propil hidrolasa del factor inducible de hipoxia (hif) para el tratamiento o prevención de la anemia. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5576323A (en) * | 1993-12-03 | 1996-11-19 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| GB9605429D0 (en) * | 1995-11-16 | 1996-05-15 | Lilly Co Eli | Excitatory amino acid receptor antagonists |
| US5688826A (en) | 1995-11-16 | 1997-11-18 | Eli Lilly And Company | Excitatory amino acid derivatives |
| ZA983930B (en) | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| HUP0400620A3 (en) * | 2001-01-11 | 2012-09-28 | Lilly Co Eli | Prodrugs of excitatory amino acids and pharmaceutical compositions containing them and process for preparation the compounds |
| EP1351925A1 (en) * | 2001-01-11 | 2003-10-15 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| EP1370519A1 (en) * | 2001-02-22 | 2003-12-17 | Eli Lilly And Company | Synthetic excitatory amino acids |
| HRP20090058A2 (hr) | 2002-06-11 | 2009-04-30 | Eli Lilly And Company | Prekursorski oblici lijekova za aminokiseline s pobuđivačkom aktivnosti |
| US7381746B2 (en) * | 2003-06-26 | 2008-06-03 | Taisho Pharmaceutical Co., Ltd. | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| AR083845A1 (es) * | 2010-11-18 | 2013-03-27 | Lilly Co Eli | COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3 |
| JP5870111B2 (ja) * | 2010-11-18 | 2016-02-24 | イーライ リリー アンド カンパニー | ｍＧｌｕＲ２／３アンタゴニストとしての４−置換−３−ベンジルオキシ−ビシクロ［３．１．０］ヘキサン化合物 |
-
2010
- 2010-12-09 AR ARP100104553A patent/AR079343A1/es active IP Right Grant
- 2010-12-09 JO JO2010439A patent/JO2978B1/en active
- 2010-12-10 TW TW099143362A patent/TWI477490B/zh active
- 2010-12-15 EP EP10798419.7A patent/EP2516406B1/en active Active
- 2010-12-15 AU AU2010340039A patent/AU2010340039B2/en active Active
- 2010-12-15 CN CN201080058183.2A patent/CN102695701B/zh active Active
- 2010-12-15 DK DK10798419.7T patent/DK2516406T3/da active
- 2010-12-15 NZ NZ600305A patent/NZ600305A/en unknown
- 2010-12-15 BR BR112012017188-7A patent/BR112012017188B1/pt active IP Right Grant
- 2010-12-15 RS RS20130530A patent/RS53063B/sr unknown
- 2010-12-15 SI SI201030387T patent/SI2516406T1/sl unknown
- 2010-12-15 SG SG2012045563A patent/SG181836A1/en unknown
- 2010-12-15 ES ES10798419T patent/ES2435651T3/es active Active
- 2010-12-15 WO PCT/US2010/060371 patent/WO2011084437A1/en not_active Ceased
- 2010-12-15 PH PH1/2012/501253A patent/PH12012501253A1/en unknown
- 2010-12-15 HR HRP20131052AT patent/HRP20131052T1/hr unknown
- 2010-12-15 KR KR1020127015935A patent/KR101395356B1/ko active Active
- 2010-12-15 EA EA201290558A patent/EA020229B1/ru not_active IP Right Cessation
- 2010-12-15 UA UAA201206909A patent/UA107684C2/ru unknown
- 2010-12-15 MX MX2012007332A patent/MX2012007332A/es active IP Right Grant
- 2010-12-15 PE PE2012000856A patent/PE20121688A1/es active IP Right Grant
- 2010-12-15 US US12/968,352 patent/US8318184B2/en active Active
- 2010-12-15 PL PL10798419T patent/PL2516406T3/pl unknown
- 2010-12-15 MY MYPI2012002794A patent/MY160618A/en unknown
- 2010-12-15 JP JP2012544727A patent/JP5779190B2/ja active Active
- 2010-12-15 PT PT107984197T patent/PT2516406E/pt unknown
- 2010-12-15 CA CA2784667A patent/CA2784667C/en active Active
-
2012
- 2012-05-24 IL IL220011A patent/IL220011A/en active IP Right Grant
- 2012-05-30 HN HN2012001160A patent/HN2012001160A/es unknown
- 2012-06-01 TN TNP2012000281A patent/TN2012000281A1/en unknown
- 2012-06-13 CR CR20120322A patent/CR20120322A/es unknown
- 2012-06-14 MA MA34967A patent/MA33824B1/fr unknown
- 2012-06-19 DO DO2012000173A patent/DOP2012000173A/es unknown
- 2012-06-20 EC ECSP12011989 patent/ECSP12011989A/es unknown
-
2013
- 2013-11-14 CY CY20131101012T patent/CY1114880T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013514974A5 (OSRAM) | ||
| JP2013514980A5 (OSRAM) | ||
| JP2013530958A5 (OSRAM) | ||
| JP2014506907A5 (OSRAM) | ||
| MX2013009709A (es) | Derivados de heteroarilo como moduladores de nachr alfa 7. | |
| JP2014526549A5 (OSRAM) | ||
| FI2291080T5 (fi) | Uusia sfingosiinifosfaattireseptorimodulaattoreita | |
| JP2015537020A5 (OSRAM) | ||
| JP2013542261A5 (OSRAM) | ||
| JP2012519182A5 (OSRAM) | ||
| JP2014511892A5 (OSRAM) | ||
| JP2014507455A5 (OSRAM) | ||
| JP2010529118A5 (OSRAM) | ||
| RU2009133262A (ru) | Нападизилатная соль антагониста мускаринового мз-рецептора | |
| JP2014515013A5 (OSRAM) | ||
| JP2013032389A5 (OSRAM) | ||
| JP2010500293A5 (OSRAM) | ||
| JP2014500861A5 (OSRAM) | ||
| HRP20131052T1 (hr) | Agonisti mglu2 | |
| JP2012507535A5 (OSRAM) | ||
| MX2013011290A (es) | Derivados de pirrol como moduladores de los receptores de acetilcolina nicotinicos para su uso en el tratamiento de enfermedades neurodegenerativas como el alzheimer y la enfermedad de parkinson. | |
| NZ596820A (en) | Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid | |
| JP2016529315A5 (OSRAM) | ||
| MX2012003720A (es) | N-((1r,2s,5r)-5-(tert-butilamino)-2-((s)-3-(7-tert-butilpirazolo[ 1,5-a][1,3,5]triazin-4-ilamino)-2-oxopirrolidin-1-il)ciclohexil)a cetamida, un modulador dual de la actividad del receptor de quimiocinas, formas cristalinas y procesos. | |
| RU2016141650A (ru) | Амидные соединения |